STERIS Free Cash Flow 2010-2024 | STE
STERIS annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- STERIS free cash flow for the quarter ending December 31, 2024 was 588.10, a year-over-year.
- STERIS free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.
- STERIS annual free cash flow for 2024 was $0.62B, a 51.46% increase from 2023.
- STERIS annual free cash flow for 2023 was $0.41B, a 2.65% increase from 2022.
- STERIS annual free cash flow for 2022 was $0.399B, a 11.52% decline from 2021.
| STERIS Annual Free Cash Flow | |
|---|---|
| 2024 | 620.33 |
| 2023 | 409.57 |
| 2022 | 398.99 |
| 2021 | 450.95 |
| 2020 | 380.20 |
| 2019 | 355.36 |
| 2018 | 294.27 |
| 2017 | 256.03 |
| 2016 | 129.11 |
| 2015 | 161.61 |
| 2014 | 128.04 |
| 2013 | 140.44 |
| 2012 | 82.73 |
| 2011 | 41.60 |
| 2010 | 183.97 |
| 2009 | 145.84 |
| STERIS Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | 588.10 |
| 2024-09-30 | 344.49 |
| 2024-06-30 | 195.66 |
| 2024-03-31 | 620.33 |
| 2023-12-31 | 457.01 |
| 2023-09-30 | 284.69 |
| 2023-06-30 | 214.53 |
| 2023-03-31 | 409.57 |
| 2022-12-31 | 262.79 |
| 2022-09-30 | 138.19 |
| 2022-06-30 | 117.10 |
| 2022-03-31 | 398.99 |
| 2021-12-31 | 300.30 |
| 2021-09-30 | 135.78 |
| 2021-06-30 | 41.25 |
| 2021-03-31 | 450.95 |
| 2020-12-31 | 337.71 |
| 2020-09-30 | 185.60 |
| 2020-06-30 | 67.40 |
| 2020-03-31 | 380.20 |
| 2019-12-31 | 238.06 |
| 2019-09-30 | 162.04 |
| 2019-06-30 | 59.56 |
| 2019-03-31 | 355.36 |
| 2018-12-31 | 252.91 |
| 2018-09-30 | 169.70 |
| 2018-06-30 | 75.85 |
| 2018-03-31 | 294.27 |
| 2017-12-31 | 216.44 |
| 2017-09-30 | 144.03 |
| 2017-06-30 | 44.17 |
| 2017-03-31 | 256.03 |
| 2016-12-31 | 181.97 |
| 2016-09-30 | 119.40 |
| 2016-06-30 | 49.49 |
| 2016-03-31 | 129.11 |
| 2015-12-31 | 22.90 |
| 2015-09-30 | 39.58 |
| 2015-06-30 | 17.66 |
| 2015-03-31 | 161.61 |
| 2014-12-31 | 109.27 |
| 2014-09-30 | 69.18 |
| 2014-06-30 | 23.09 |
| 2014-03-31 | 128.04 |
| 2013-12-31 | 82.13 |
| 2013-09-30 | 32.94 |
| 2013-06-30 | 10.96 |
| 2013-03-31 | 140.44 |
| 2012-12-31 | 117.09 |
| 2012-09-30 | 66.98 |
| 2012-06-30 | 45.74 |
| 2012-03-31 | 82.73 |
| 2011-12-31 | 58.60 |
| 2011-09-30 | 26.09 |
| 2011-06-30 | -3.61 |
| 2011-03-31 | 41.60 |
| 2010-12-31 | 28.31 |
| 2010-09-30 | 29.31 |
| 2010-06-30 | 17.29 |
| 2010-03-31 | 183.97 |
| 2009-12-31 | 129.40 |
| 2009-09-30 | 74.37 |
| 2009-06-30 | 24.44 |
| 2009-03-31 | 145.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.550B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $212.123B | 97.31 |
| Thermo Fisher Scientific (TMO) | United States | $203.433B | 24.33 |
| Edwards Lifesciences (EW) | United States | $44.937B | 29.08 |
| Alcon (ALC) | Switzerland | $44.417B | 29.72 |
| IDEXX Laboratories (IDXX) | United States | $36.400B | 41.66 |
| DexCom (DXCM) | United States | $34.790B | 53.98 |
| IQVIA Holdings (IQV) | United States | $34.065B | 18.87 |
| Mettler-Toledo (MTD) | United States | $26.604B | 30.90 |
| Waters (WAT) | United States | $21.953B | 31.15 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.044B | 0.00 |
| Hologic (HOLX) | United States | $14.190B | 15.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.755B | 14.12 |
| Globus Medical (GMED) | United States | $11.429B | 28.94 |
| Sysmex ADR (SSMXY) | Japan | $11.267B | 35.33 |
| Penumbra (PEN) | United States | $10.311B | 101.00 |
| Masimo (MASI) | United States | $9.707B | 46.97 |
| Glaukos (GKOS) | United States | $8.447B | 0.00 |
| Teleflex (TFX) | United States | $7.776B | 12.40 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.679B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.528B | 0.00 |
| Veracyte (VCYT) | United States | $3.186B | 95.61 |
| Nihon Kohden (NHNKY) | Japan | $2.705B | 14.78 |
| LivaNova (LIVN) | United Kingdom | $2.589B | 14.95 |
| TransMedics (TMDX) | United States | $2.422B | 76.79 |
| Elekta AB (EKTAY) | Sweden | $2.392B | 21.50 |
| Tandem Diabetes Care (TNDM) | United States | $2.198B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.866B | 9.75 |
| Alphatec Holdings (ATEC) | United States | $1.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.291B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 83.50 |
| RxSight (RXST) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.798B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.792B | 17.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.762B | 12.94 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.711B | 0.00 |
| IRadimed (IRMD) | United States | $0.700B | 36.82 |
| SiBone (SIBN) | United States | $0.687B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.628B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.521B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.505B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.460B | 24.23 |
| AngioDynamics (ANGO) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| NeuroPace (NPCE) | United States | $0.367B | 0.00 |
| CVRx (CVRX) | United States | $0.366B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.287B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.132B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.127B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 13.77 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 30.14 |
| Microbot Medical (MBOT) | United States | $0.057B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |